Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy
Falkensammer,B.; El Attal,R.; Mullauer,B.; Sarcletti,M.; Parson,W.; Dierich,M.P.; Stoiber,H.;
The standard treatment for HIV infected patients is the highly active antiretroviral therapy. Due to resistance developments treatment failure can be found in some patients. In our study two different strategies are compared, which may reduce resistance mutations. Six patients (group A and B) have been monitored for about six years. Group A patients had a switch in their AZT-containing treatment to non AZT-containing regimens.
[Read More]